ONCOLOGY CONTRACT 
MANUFACTURING

At Baxter’s manufacturing facility dedicated to oncology products in Halle/Westfalen, Germany, all of your parenteral needs are handled at one location, enabling processing solutions to fit your compound.

Your oncology products can make a difference in patients’ lives. 

Our oncology manufacturing expertise can help you make that difference.

Global Experience

More than 60 years of oncology experience manufacturing products sold worldwide including North America, South America, Europe and Asia.

Broad Expertise

Dedicated clinical through commercial production with integrated technologies and services. Specialized areas of focus include cytotoxics, highly potent compounds, biologics, lyophilized products, and antibody-drug conjugates (ADCs).

Maximizing Manufacturing Value

Baxter’s Halle facility offers state-of-the-art cGMP manufacturing, uniquely designed to deliver high-quality products with optimum efficiency and speed to market.

To discuss sterile contract manufacturing services for injectable molecules, please contact us at: 
United States: 1-800-4-BAXTER 
International: 1-224-948-4770

Go to article: Home | US excess vs. global accessGo to article: EditorialGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: ContentsGo to article: ELPRO Monitoring SolutionsGo to article: NewsGo to article: BaxterGo to article: The pharma industry briefingGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: Turning pharma green: an eco-wish list for the industryGo to article: Scandinavian Health Company InsightGo to article: Scandinavian HealthGo to article: Q&A: disrupting DNA synthesis with Twist’s Emily LeproustGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: Tips and tricks for regulating advanced therapiesGo to article: Gerteis Company InsightGo to article: GerteisGo to article: Lyme disease: what's actually going on here?Go to article: Subcuject Company Insight Go to article: SubcujectGo to article: The US and the developing world: a tale of two opioid crises Go to article: KugelmeiersGo to article: Tracking priority medicines in transit: UPS launches tech-enabled serviceGo to article: Modality SolutionsGo to article: When deadlines turn deadly: examining the psychology of drug regulatorsGo to article: Zenatek Go to article: Proteus Digital Health: a sharp lesson for smart pills?Go to article: MimotopesGo to article: Deals in brief powered by GlobalDataGo to article: MicronovaGo to article: The key list powered by GlobalDataGo to article: EmisphereGo to article: Markets and Indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: Air FranceGo to article: EventsGo to article: ILC Dover Go to article: Next issue